Pharmalink Healthcare

Tamobix (Tamoxifen Citrate 20 mg) is a selective estrogen receptor modulator (SERM) primarily used in the treatment and prevention of breast cancer. It works by blocking estrogen receptors in breast tissue, preventing estrogen from promoting the growth of hormone-sensitive cancer cells. The 20 mg tablet provides effective daily dosing for both treatment and preventive therapy. Tamobix is often prescribed for early-stage and advanced breast cancer, as well as for reducing the risk of recurrence after surgery. It is also used in some cases to support fertility treatment by inducing ovulation in women with ovulatory dysfunction. The medication helps improve survival rates and reduce tumor progression. Tamobix is valued for its reliability, proven efficacy, and manageable side-effect profile. Regular use under medical supervision ensures optimal therapeutic outcomes and safety. It helps patients maintain hormonal balance while targeting cancerous cells. The tablet form is easy to administer, supporting long-term adherence. Proper adherence enhances treatment effectiveness and reduces the risk of cancer recurrence.